After pharmaceutical company AstraZeneca announced the resumption of its Covid-19 vaccine trial in the UK, its partner at India Serum Institute said it will also restart trials once the General Medicines Controller of India (DGCI) gives its okay. The DGCI previously sent a show of cause notice to the Pune-based …
Read More »Serum Institute to resume Covid-19 vaccine trial after DGCI gives its go-ahead
